Spire Wellesley Hospital

Published measure: Trauma and Orthopaedic Service: ongoing pathways

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site.

Referral-to-treatment waiting times · Coverage and method

Published measure: Other - Surgical Services: ongoing pathways

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site.

Referral-to-treatment waiting times · Coverage and method

Published measure: General Surgery Service: ongoing pathways within 18 weeks

The calculation uses a denominator of 119; see the source for the eligible group.

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site. Uses pathways with a known clock start date. This is elapsed waiting time, not a prediction of the remaining wait.

Referral-to-treatment waiting times · Coverage and method

Published measure: Trauma and Orthopaedic Service: ongoing pathways within 18 weeks

The calculation uses a denominator of 1,070; see the source for the eligible group.

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site. Uses pathways with a known clock start date. This is elapsed waiting time, not a prediction of the remaining wait.

Referral-to-treatment waiting times · Coverage and method

Published measure: Other - Surgical Services: ongoing pathways within 18 weeks

The calculation uses a denominator of 10; see the source for the eligible group.

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site. Uses pathways with a known clock start date. This is elapsed waiting time, not a prediction of the remaining wait.

Referral-to-treatment waiting times · Coverage and method

Published measure: General Surgery Service: ongoing pathways over 52 weeks

The calculation uses a denominator of 119; see the source for the eligible group.

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site.

Referral-to-treatment waiting times · Coverage and method

Published measure: Trauma and Orthopaedic Service: ongoing pathways over 52 weeks

The calculation uses a denominator of 1,070; see the source for the eligible group.

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site.

Referral-to-treatment waiting times · Coverage and method

Published measure: Total: ongoing pathways over 52 weeks

The calculation uses a denominator of 1,199; see the source for the eligible group.

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site.

Referral-to-treatment waiting times · Coverage and method

Published measure: Other - Surgical Services: ongoing pathways over 52 weeks

The calculation uses a denominator of 10; see the source for the eligible group.

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site.

Referral-to-treatment waiting times · Coverage and method

Published measure: General Surgery Service: completed admitted pathways

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site. Completed admitted and non-admitted pathways describe different cohorts.

Referral-to-treatment waiting times · Coverage and method

Published measure: General Surgery Service: completed non-admitted pathways

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site. Completed admitted and non-admitted pathways describe different cohorts.

Referral-to-treatment waiting times · Coverage and method

Published measure: Trauma and Orthopaedic Service: completed admitted pathways

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site. Completed admitted and non-admitted pathways describe different cohorts.

Referral-to-treatment waiting times · Coverage and method

Published measure: Trauma and Orthopaedic Service: completed non-admitted pathways

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site. Completed admitted and non-admitted pathways describe different cohorts.

Referral-to-treatment waiting times · Coverage and method

Published measure: Ear Nose and Throat Service: completed non-admitted pathways

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site. Completed admitted and non-admitted pathways describe different cohorts.

Referral-to-treatment waiting times · Coverage and method

Published measure: Total: completed admitted pathways

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site. Completed admitted and non-admitted pathways describe different cohorts.

Referral-to-treatment waiting times · Coverage and method

Published measure: Total: completed non-admitted pathways

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site. Completed admitted and non-admitted pathways describe different cohorts.

Referral-to-treatment waiting times · Coverage and method

Published measure: Other - Surgical Services: completed non-admitted pathways

Provider-level NHS RTT pathways aggregated across commissioners. A person can have multiple pathways. Specialty figures do not identify the wait for a particular procedure or hospital site. Completed admitted and non-admitted pathways describe different cohorts.

Referral-to-treatment waiting times · Coverage and method

Published measure: PERIPHERAL_NEUROPHYS: patients on the reported waiting list

Diagnostic waiting list and activity at reporting-provider level. Planned and unscheduled activity are separate from the waiting-list cohort. Not a live booking estimate.

Diagnostic waiting times and activity · Coverage and method

Published measure: TOTAL: patients on the reported waiting list

Diagnostic waiting list and activity at reporting-provider level. Planned and unscheduled activity are separate from the waiting-list cohort. Not a live booking estimate.

Diagnostic waiting times and activity · Coverage and method

Published measure: CT: waiting six weeks or longer

The calculation uses a denominator of 8; see the source for the eligible group.

Diagnostic waiting list and activity at reporting-provider level. Planned and unscheduled activity are separate from the waiting-list cohort. Not a live booking estimate.

Diagnostic waiting times and activity · Coverage and method

Published measure: MRI: waiting six weeks or longer

The calculation uses a denominator of 81; see the source for the eligible group.

Diagnostic waiting list and activity at reporting-provider level. Planned and unscheduled activity are separate from the waiting-list cohort. Not a live booking estimate.

Diagnostic waiting times and activity · Coverage and method

Published measure: NON_OBSTETRIC_ULTRASOUND: waiting six weeks or longer

The calculation uses a denominator of 12; see the source for the eligible group.

Diagnostic waiting list and activity at reporting-provider level. Planned and unscheduled activity are separate from the waiting-list cohort. Not a live booking estimate.

Diagnostic waiting times and activity · Coverage and method

Published measure: TOTAL: waiting six weeks or longer

The calculation uses a denominator of 101; see the source for the eligible group.

Diagnostic waiting list and activity at reporting-provider level. Planned and unscheduled activity are separate from the waiting-list cohort. Not a live booking estimate.

Diagnostic waiting times and activity · Coverage and method

Published measure: CT: reported diagnostic activity

Diagnostic waiting list and activity at reporting-provider level. Planned and unscheduled activity are separate from the waiting-list cohort. Not a live booking estimate.

Diagnostic waiting times and activity · Coverage and method

Published measure: MRI: reported diagnostic activity

Diagnostic waiting list and activity at reporting-provider level. Planned and unscheduled activity are separate from the waiting-list cohort. Not a live booking estimate.

Diagnostic waiting times and activity · Coverage and method

Published measure: NON_OBSTETRIC_ULTRASOUND: reported diagnostic activity

Diagnostic waiting list and activity at reporting-provider level. Planned and unscheduled activity are separate from the waiting-list cohort. Not a live booking estimate.

Diagnostic waiting times and activity · Coverage and method

Published measure: PERIPHERAL_NEUROPHYS: reported diagnostic activity

Diagnostic waiting list and activity at reporting-provider level. Planned and unscheduled activity are separate from the waiting-list cohort. Not a live booking estimate.

Diagnostic waiting times and activity · Coverage and method

Published measure: TOTAL: reported diagnostic activity

Diagnostic waiting list and activity at reporting-provider level. Planned and unscheduled activity are separate from the waiting-list cohort. Not a live booking estimate.

Diagnostic waiting times and activity · Coverage and method

Published measure: Hip Replacement Primary · EQ-5D Index: Unadjusted preoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ-5D Index: Unadjusted health gain

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ-5D Index: Questionnaire pairs with improvement

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ-5D Index: Modelled questionnaire pairs

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ-5D Index: Questionnaire pairs with unchanged score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ-5D Index: Questionnaire pairs with deterioration

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ VAS: Case-mix-adjusted health gain

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ VAS: Case-mix-adjusted postoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ VAS: Unadjusted postoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ VAS: Unadjusted preoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ VAS: Unadjusted health gain

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ VAS: Questionnaire pairs with improvement

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ VAS: Modelled questionnaire pairs

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ VAS: Questionnaire pairs with unchanged score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · EQ VAS: Questionnaire pairs with deterioration

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · Oxford Hip Score: Case-mix-adjusted health gain

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · Oxford Hip Score: Case-mix-adjusted postoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · Oxford Hip Score: Unadjusted postoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · Oxford Hip Score: Unadjusted preoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · Oxford Hip Score: Unadjusted health gain

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · Oxford Hip Score: Questionnaire pairs with improvement

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · Oxford Hip Score: Modelled questionnaire pairs

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · Oxford Hip Score: Questionnaire pairs with unchanged score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Hip Replacement Primary · Oxford Hip Score: Questionnaire pairs with deterioration

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ-5D Index: Case-mix-adjusted health gain

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ-5D Index: Case-mix-adjusted postoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ-5D Index: Unadjusted postoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ-5D Index: Unadjusted preoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ-5D Index: Unadjusted health gain

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ-5D Index: Questionnaire pairs with improvement

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ-5D Index: Modelled questionnaire pairs

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ-5D Index: Questionnaire pairs with unchanged score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ-5D Index: Questionnaire pairs with deterioration

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ VAS: Case-mix-adjusted health gain

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ VAS: Case-mix-adjusted postoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ VAS: Unadjusted postoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ VAS: Unadjusted preoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ VAS: Unadjusted health gain

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ VAS: Questionnaire pairs with improvement

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ VAS: Modelled questionnaire pairs

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ VAS: Questionnaire pairs with unchanged score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · EQ VAS: Questionnaire pairs with deterioration

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · Oxford Knee Score: Case-mix-adjusted health gain

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · Oxford Knee Score: Case-mix-adjusted postoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · Oxford Knee Score: Unadjusted postoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · Oxford Knee Score: Unadjusted preoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · Oxford Knee Score: Unadjusted health gain

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · Oxford Knee Score: Questionnaire pairs with improvement

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · Oxford Knee Score: Modelled questionnaire pairs

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · Oxford Knee Score: Questionnaire pairs with unchanged score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Knee Replacement Primary · Oxford Knee Score: Questionnaire pairs with deterioration

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ-5D Index: Case-mix-adjusted health gain

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ-5D Index: Case-mix-adjusted postoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ-5D Index: Unadjusted postoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ-5D Index: Unadjusted preoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ-5D Index: Unadjusted health gain

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ-5D Index: Questionnaire pairs with improvement

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ-5D Index: Modelled questionnaire pairs

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ-5D Index: Questionnaire pairs with unchanged score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ-5D Index: Questionnaire pairs with deterioration

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ VAS: Case-mix-adjusted health gain

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ VAS: Case-mix-adjusted postoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ VAS: Unadjusted postoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ VAS: Unadjusted preoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ VAS: Unadjusted health gain

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ VAS: Questionnaire pairs with improvement

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ VAS: Modelled questionnaire pairs

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ VAS: Questionnaire pairs with unchanged score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · EQ VAS: Questionnaire pairs with deterioration

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · Oxford Hip Score: Case-mix-adjusted health gain

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · Oxford Hip Score: Case-mix-adjusted postoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · Oxford Hip Score: Unadjusted postoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · Oxford Hip Score: Unadjusted preoperative score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · Oxford Hip Score: Unadjusted health gain

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · Oxford Hip Score: Questionnaire pairs with improvement

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · Oxford Hip Score: Modelled questionnaire pairs

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · Oxford Hip Score: Questionnaire pairs with unchanged score

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Hip Replacement · Oxford Hip Score: Questionnaire pairs with deterioration

Reported sample: 43.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ-5D Index: Case-mix-adjusted health gain

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ-5D Index: Case-mix-adjusted postoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ-5D Index: Unadjusted postoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ-5D Index: Unadjusted preoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ-5D Index: Unadjusted health gain

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ-5D Index: Questionnaire pairs with improvement

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ-5D Index: Modelled questionnaire pairs

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ-5D Index: Questionnaire pairs with unchanged score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ-5D Index: Questionnaire pairs with deterioration

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ VAS: Case-mix-adjusted health gain

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ VAS: Case-mix-adjusted postoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ VAS: Unadjusted postoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ VAS: Unadjusted preoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ VAS: Unadjusted health gain

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ VAS: Questionnaire pairs with improvement

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ VAS: Modelled questionnaire pairs

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ VAS: Questionnaire pairs with unchanged score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · EQ VAS: Questionnaire pairs with deterioration

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · Oxford Knee Score: Case-mix-adjusted health gain

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · Oxford Knee Score: Case-mix-adjusted postoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · Oxford Knee Score: Unadjusted postoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · Oxford Knee Score: Unadjusted preoperative score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · Oxford Knee Score: Unadjusted health gain

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · Oxford Knee Score: Questionnaire pairs with improvement

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · Oxford Knee Score: Modelled questionnaire pairs

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · Oxford Knee Score: Questionnaire pairs with unchanged score

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Total Knee Replacement · Oxford Knee Score: Questionnaire pairs with deterioration

Reported sample: 66.

Published NHS-funded hip or knee replacement questionnaire aggregates for April 2024–March 2025. Primary and revision procedures and the different questionnaires are separate cohorts. Results describe respondents with modelled questionnaire pairs, not every surgical patient or a personal prediction. Adjusted scores account for measured case mix; small differences do not establish statistically significant differences. Case-mix-adjusted results are withheld below 30 modelled pairs. Negative health gains and EQ-5D scores can be valid. Source reporting code: NT313.

Patient Reported Outcome Measures: hip and knee replacement · Coverage and method

Published measure: Dementia assessment

2025 patient-led assessment of the non-clinical environment; not a clinical outcome or a current accessibility audit. Assessments involve staff and patient assessors and include judgement. Participation is voluntary and coverage differs. Check present-day facilities directly before travelling. Site assessment; do not substitute the parent organisation score.

PLACE: hospital environment assessments · Coverage and method

Published measure: Disability assessment

2025 patient-led assessment of the non-clinical environment; not a clinical outcome or a current accessibility audit. Assessments involve staff and patient assessors and include judgement. Participation is voluntary and coverage differs. Check present-day facilities directly before travelling. Site assessment; do not substitute the parent organisation score.

PLACE: hospital environment assessments · Coverage and method

Published measure: Organisation Food assessment

2025 patient-led assessment of the non-clinical environment; not a clinical outcome or a current accessibility audit. Assessments involve staff and patient assessors and include judgement. Participation is voluntary and coverage differs. Check present-day facilities directly before travelling. Site assessment; do not substitute the parent organisation score.

PLACE: hospital environment assessments · Coverage and method

Published measure: Privacy, Dignity and Wellbeing assessment

2025 patient-led assessment of the non-clinical environment; not a clinical outcome or a current accessibility audit. Assessments involve staff and patient assessors and include judgement. Participation is voluntary and coverage differs. Check present-day facilities directly before travelling. Site assessment; do not substitute the parent organisation score.

PLACE: hospital environment assessments · Coverage and method

Published measure: Ward Food assessment

2025 patient-led assessment of the non-clinical environment; not a clinical outcome or a current accessibility audit. Assessments involve staff and patient assessors and include judgement. Participation is voluntary and coverage differs. Check present-day facilities directly before travelling. Site assessment; do not substitute the parent organisation score.

PLACE: hospital environment assessments · Coverage and method